Perseus Proteomics Inc. (TYO:4882)
Japan
· Delayed Price · Currency is JPY 407.00
+7.00 (1.75%)
Jun 25, 2025, 3:30 PM JST
Perseus Proteomics Revenue
In the fiscal year ending March 31, 2025, Perseus Proteomics had annual revenue of 120.38M JPY with 20.38% growth. Perseus Proteomics had revenue of 37.31M in the quarter ending March 31, 2025, with 28.64% growth.
Revenue
120.38M
Revenue Growth
+20.38%
P/S Ratio
49.01
Revenue / Employee
n/a
Employees
25
Market Cap
5.90B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,222.12B |
| Takeda Pharmaceutical Company | 4,581.55B |
| Daiichi Sankyo Company | 1,886.26B |
| HOYA Corporation | 866.03B |
| Terumo | 1,036.17B |
| Otsuka Holdings | 2,393.18B |
| Astellas Pharma | 1,912.32B |
| Olympus | 997.33B |